3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Urinary Bladder Neoplasms
2
Non-Muscle Invasive Bladder Neoplasms
2
Interventions
Gemcitabine
19
Mitomycin
10
Docetaxel
7
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
5-aminolevulinic acid hexyl ester
×
1 year
×
Clear all
NCT05962541
2025-12-31
CUT-less
University of Roma La Sapienza
Phase 4
Recruiting
327 enrolled
NCT02660645
2025-12-18
BLCCR
Photocure
Recruiting
4,400 enrolled